Aster DM Healthcare Q4 net profit jumps 21% on margin gains; merger with Quality Care advances

Aster added 300 beds in FY25, bringing total capacity to 5,159 beds

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Hospital chain Aster DM Healthcare on Tuesday reported a 21% year-on-year increase to Rs 106  in normalized profit after tax for the quarter ended March 31, 2025, due to improved operational efficiency and a better payor mix helped offset modest revenue growth.

The company also said its proposed merger with Quality Care India Ltd., backed by Blackstone, is progressing through regulatory approvals.

Revenue for Q4 FY25 rose 2% YoY to Rs 1,000 crore, while operating EBITDA grew 16% to Rs 193 crore. EBITDA margin expanded to 19.3% from 17.1% a year earlier. Normalized PAT stood at Rs 106 crore, compared to Rs 87 crore in Q4 FY24.

“Our Q4 performance reflects continued focus on operational excellence and patient-centric care,” said Dr. Azad Moopen, Founder and Chairman. “We are also excited about the transformative potential of our merger with Quality Care, which will significantly enhance our scale and capabilities.”

For the Full-Year FY25, revenue rose 12% YoY to Rs 4,138 crore, operating EBITDA increased 30% to Rs 806 crore and EBITDA margin improved to 19.5% from 16.8%. Normalized PAT surged 49% to Rs 357 crore

The operational metrics including average length of stay (ALOS) improved to 3.2 days from 3.4. Insurance and cash payor mix rose to 88%, up 250 basis points YoY.

Hospital business EBITDA margin reached 21.9%; matured hospitals delivered 24.3% margin and 34% ROCE

Aster added 300 beds in FY25, bringing total capacity to 5,159 beds. The company plans to add over 2,100 beds to reach 7,300 beds. It also launched India’s first intraoperative electron radiation therapy program and rolled out the Aster Health app across its network.

Aster Labs revenue rose 12% YoY, with an 8% EBITDA margin

The company said the merger with Quality Care India Ltd. has received shareholder, competition commission of India (CCI), and stock exchange approvals. Aster has completed a preferential allotment of 3.6% stake to Blackstone and TPG. The transaction is expected to close by Q4FY26, pending NCLT approval.